{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:16:47Z","timestamp":1766067407624,"version":"3.48.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Laboratory of Yunnan Provincial Innovative Application of Traditional Chinese Medicine","award":["202305AV340006"],"award-info":[{"award-number":["202305AV340006"]}]},{"name":"Science and Technology plan project of the First People\u2019s Hospital of Yunnan Province","award":["KHBS-2022-024"],"award-info":[{"award-number":["KHBS-2022-024"]}]},{"name":"Yunnan Science and Technology Commission of the Yunnan Provincial Science and Technology Department and Kunming Medical University","award":["202401AY070001-123"],"award-info":[{"award-number":["202401AY070001-123"]}]},{"name":"Kunming University of Science and Technology & the First People\u2019s Hospital of Yunnan Province Joint Special Project on Medical Research","award":["KUST-KH2022020Y"],"award-info":[{"award-number":["KUST-KH2022020Y"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27751-x","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:37:31Z","timestamp":1765802251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sodium new houttuyfonate affects tumor angiogenesis by suppressing FGF1 expression and the p38\/MAPK signaling pathway in pancreatic cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Xin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"27751_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J Clin"},{"key":"27751_CR2","doi-asserted-by":"publisher","unstructured":"H A rd, B. et al. Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial. J Clin Oncol. https:\/\/doi.org\/10.1200\/jco.22.02777 (2023).","DOI":"10.1200\/jco.22.02777"},{"key":"27751_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S1470-2045(24)00511-4","volume":"25","author":"L Mastrantoni","year":"2024","unstructured":"Mastrantoni, L. et al. Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis. Lancet Oncol. 25, 1655\u20131665. https:\/\/doi.org\/10.1016\/S1470-2045(24)00511-4 (2024).","journal-title":"Lancet Oncol."},{"key":"27751_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-08001-4","author":"Z Wenming","year":"2025","unstructured":"Wenming, Z. et al. The deubiquitylase OTUB1 drives gemcitabine resistance in pancreatic cancer by enhancing pyrimidine metabolism through modulating DHODH mRNA stability. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-025-08001-4 (2025).","journal-title":"Cell Death Dis."},{"key":"27751_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/gad.348523.121","author":"L Gregory","year":"2021","unstructured":"Gregory, L. et al. The biological underpinnings of therapeutic resistance in pancreatic cancer. Genes Dev https:\/\/doi.org\/10.1101\/gad.348523.121 (2021).","journal-title":"Genes Dev"},{"key":"27751_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/1078155217719584","volume":"24","author":"D Gill","year":"2018","unstructured":"Gill, D. et al. Gemcitabine associated pseudocellulitis: A missed diagnosis. J Oncol Pharm Pract 24, 550\u2013552. https:\/\/doi.org\/10.1177\/1078155217719584 (2018).","journal-title":"J Oncol Pharm Pract"},{"key":"27751_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.09.009","author":"B Xueli","year":"2025","unstructured":"Xueli, B. et al. Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial. Cancer Cell https:\/\/doi.org\/10.1016\/j.ccell.2025.09.009 (2025).","journal-title":"Cancer Cell"},{"key":"27751_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.seminoncol.2010.06.014","volume":"37","author":"N Gullett","year":"2010","unstructured":"Gullett, N. et al. Cancer prevention with natural compounds. Semin. Oncol. 37, 258\u2013281. https:\/\/doi.org\/10.1053\/j.seminoncol.2010.06.014 (2010).","journal-title":"Semin. Oncol."},{"key":"27751_CR9","doi-asserted-by":"publisher","DOI":"10.1039\/c8ra04879g","author":"Y Muhammad","year":"2018","unstructured":"Muhammad, Y., Christophe, H. & Nathalie, G.-G. Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives. RSC Adv https:\/\/doi.org\/10.1039\/c8ra04879g (2018).","journal-title":"RSC Adv"},{"key":"27751_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/biof.2115","author":"A Seyed Sajad","year":"2024","unstructured":"Seyed Sajad, A. et al. Harnessing the therapeutic potential of phytochemicals in neuroblastoma. BioFactors https:\/\/doi.org\/10.1002\/biof.2115 (2024).","journal-title":"BioFactors"},{"key":"27751_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12715-7","author":"F Sajad","year":"2024","unstructured":"Sajad, F. et al. Phytochemicals regulate cancer metabolism through modulation of the AMPK\/PGC-1\u03b1 signaling pathway. BMC Cancer https:\/\/doi.org\/10.1186\/s12885-024-12715-7 (2024).","journal-title":"BMC Cancer"},{"key":"27751_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1577561","author":"B Yilin","year":"2025","unstructured":"Yilin, B. et al. Efficacy of sodium new houttuyfonate against Aspergillus flavus: insights from in vitro and in vivo models of invasive pulmonary aspergillosis. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1577561 (2025).","journal-title":"Front Pharmacol."},{"key":"27751_CR13","doi-asserted-by":"publisher","DOI":"10.2174\/1389201024666230418163100","author":"H Xiaomei","year":"2023","unstructured":"Xiaomei, H. et al. Sodium New Houttuyfonate Effectively Improves Phagocytosis and Inhibits the Excessive Release of Inflammatory Factors by Repressing TLR4\/NF-\u041ab Pathway in Macrophages. Curr Pharm Biotechnol. https:\/\/doi.org\/10.2174\/1389201024666230418163100 (2023).","journal-title":"Curr Pharm Biotechnol."},{"key":"27751_CR14","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.3389\/fmicb.2020.02075","volume":"11","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. Candida albicansSodium New Houttuyfonate Inhibits Biofilm Formation by Inhibiting the Ras1-cAMP-Efg1 Pathway Revealed by RNA-seq. Front. Microbiol. 11, 2075. https:\/\/doi.org\/10.3389\/fmicb.2020.02075 (2020).","journal-title":"Front. Microbiol."},{"key":"27751_CR15","doi-asserted-by":"publisher","first-page":"856272","DOI":"10.3389\/fmicb.2022.856272","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Aspergillus fumigatus in vitroAntifungal Activity of Sodium New Houttuyfonate Against and. Front. Microbiol. 13, 856272. https:\/\/doi.org\/10.3389\/fmicb.2022.856272 (2022).","journal-title":"Front. Microbiol."},{"key":"27751_CR16","doi-asserted-by":"publisher","unstructured":"K H, C., M C, P., Thomas, P., Benny K H, T. & Vincent T, C. Evaluation of antiviral activities of Houttuynia cordata Thunb extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac J Trop Med. https:\/\/doi.org\/10.1016\/j.apjtm.2015.12.002 (2016).","DOI":"10.1016\/j.apjtm.2015.12.002"},{"key":"27751_CR17","doi-asserted-by":"publisher","unstructured":"Pang, J. et al. Purification of houttuynia cordata thunb essential oil using macroporous resin followed by microemulsion encapsulation to improve its safety and antiviral activity. Molecules (Basel, Switzerland). https:\/\/doi.org\/10.3390\/molecules22020293 (2017).","DOI":"10.3390\/molecules22020293"},{"key":"27751_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051614","author":"L He","year":"2023","unstructured":"He, L. et al. Sodium New Houttuyfonate Induces Apoptosis of Breast Cancer Cells via ROS\/PDK1\/AKT\/GSK3\u03b2 Axis. Cancers https:\/\/doi.org\/10.3390\/cancers15051614 (2023).","journal-title":"Cancers"},{"key":"27751_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13402","volume":"56","author":"R Jiang","year":"2023","unstructured":"Jiang, R. et al. The sodium new houttuyfonate suppresses NSCLC via activating pyroptosis through TCONS-14036\/miR-1228-5p\/PRKCDBP pathway. Cell Prolif. 56, e13402. https:\/\/doi.org\/10.1111\/cpr.13402 (2023).","journal-title":"Cell Prolif."},{"key":"27751_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246111","author":"F Jia","year":"2022","unstructured":"Jia, F. et al. Fusobacterium nucleatum (Fn)Sodium New Houttuyfonate Inhibits Cancer-Promoting to Reduce Colorectal Cancer Progression. Cancers https:\/\/doi.org\/10.3390\/cancers14246111 (2022).","journal-title":"Cancers"},{"key":"27751_CR21","doi-asserted-by":"publisher","DOI":"10.1039\/c9ra06024c","author":"Y Linsong","year":"2019","unstructured":"Linsong, Y. et al. Anti-tumor effect of volatile oil from Houttuynia cordata Thunb on HepG2 cells and HepG2 tumor-bearing mice. RSC Adv https:\/\/doi.org\/10.1039\/c9ra06024c (2019).","journal-title":"RSC Adv"},{"key":"27751_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1152-9","author":"J Rilei","year":"2019","unstructured":"Rilei, J. et al. Sodium new houttuyfonate suppresses metastasis in NSCLC cells through the Linc00668\/miR-147a\/slug axis. J Exp Clin Cancer Res. https:\/\/doi.org\/10.1186\/s13046-019-1152-9 (2019).","journal-title":"J Exp Clin Cancer Res."},{"key":"27751_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"A Hosein","year":"2020","unstructured":"Hosein, A., Brekken, R. & Maitra, A. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat. Rev. Gastroenterol. Hepatol. 17, 487\u2013505. https:\/\/doi.org\/10.1038\/s41575-020-0300-1 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"27751_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178357","author":"A Arian","year":"2025","unstructured":"Arian, A. et al. P-21 Kinase 1 or 4 Knockout Stimulated Anti-Tumour Immunity Against Pancreatic Cancer by Enhancing Vascular Normalisation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26178357 (2025).","journal-title":"Int J Mol Sci."},{"key":"27751_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1625114","author":"Y Yuzhang","year":"2025","unstructured":"Yuzhang, Y. et al. The role of inflammatory factors in the tumor microenvironment of pancreatic cancer. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1625114 (2025).","journal-title":"Front Immunol."},{"key":"27751_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds134","author":"LK, M.","year":"2012","unstructured":"LK, M., et al. VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA. Ann Oncol https:\/\/doi.org\/10.1093\/annonc\/mds134 (2012).","journal-title":"Ann Oncol"},{"key":"27751_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cas.13441","volume":"109","author":"K Saito","year":"2018","unstructured":"Saito, K. et al. Xanthohumol inhibits angiogenesis by suppressing nuclear factor-\u03baB activation in pancreatic cancer. Cancer Sci. 109, 132\u2013140. https:\/\/doi.org\/10.1111\/cas.13441 (2018).","journal-title":"Cancer Sci."},{"key":"27751_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01478-5","author":"H Chongbiao","year":"2023","unstructured":"Chongbiao, H. et al. BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-023-01478-5 (2023).","journal-title":"Signal Transduct Target Ther."},{"key":"27751_CR29","doi-asserted-by":"publisher","unstructured":"Rougier, P. et al. Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer. European journal of cancer (Oxford, England : 1990) 49, 2633\u20132642, https:\/\/doi.org\/10.1016\/j.ejca.2013.04.002 (2013).","DOI":"10.1016\/j.ejca.2013.04.002"},{"key":"27751_CR30","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1200\/jco.2010.28.1386","volume":"28","author":"H Kindler","year":"2010","unstructured":"Kindler, H. et al. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). Journal of clinical oncology\u202f: official journal of the American Society of Clinical Oncology 28, 3617\u20133622. https:\/\/doi.org\/10.1200\/jco.2010.28.1386 (2010).","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"27751_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res"},{"key":"27751_CR32","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci"},{"key":"27751_CR33","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res 53, D672-d677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res"},{"key":"27751_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2016.04.007","author":"T Thibaud","year":"2016","unstructured":"Thibaud, T. et al. A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2. Mech Ageing Dev https:\/\/doi.org\/10.1016\/j.mad.2016.04.007 (2016).","journal-title":"Mech Ageing Dev"},{"key":"27751_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00288-4","author":"H Hai","year":"2017","unstructured":"Hai, H. et al. Elevated COX-2 Expression Promotes Angiogenesis Through EGFR\/p38-MAPK\/Sp1-Dependent Signalling in Pancreatic Cancer. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-00288-4 (2017).","journal-title":"Sci Rep."},{"key":"27751_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057927","author":"M Seiji","year":"2013","unstructured":"Seiji, M. et al. A dominant-negative FGF1 mutant (the R50E mutant) suppresses tumorigenesis and angiogenesis. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0057927 (2013).","journal-title":"PLoS ONE"},{"key":"27751_CR37","first-page":"419","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Tumor-derived Immunoglobulin-like transcript 4 facilitates angiogenesis of colorectal cancer. Am J Cancer Res 13, 419\u2013435 (2023).","journal-title":"Am J Cancer Res"},{"key":"27751_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495\u2013501. https:\/\/doi.org\/10.1038\/nature14169 (2015).","journal-title":"Nature"},{"key":"27751_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.10.037","author":"K Avnish","year":"2019","unstructured":"Avnish, K. et al. Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer. Cell https:\/\/doi.org\/10.1016\/j.cell.2019.10.037 (2019).","journal-title":"Cell"},{"key":"27751_CR40","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1038\/s41467-024-46811-w","volume":"15","author":"A Bulle","year":"2024","unstructured":"Bulle, A. et al. Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer. Nat Commun 15, 2503. https:\/\/doi.org\/10.1038\/s41467-024-46811-w (2024).","journal-title":"Nat Commun"},{"key":"27751_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/lifemedi\/lnae023","author":"Y Xiahong","year":"2025","unstructured":"Xiahong, Y., Longyu, D., Mingjia, T., Xiufang, X. & Yi, S. SHOC2 plays an oncogenic or tumor-suppressive role by differentially targeting the MAPK and mTORC1 signals in liver cancer. Life Med. https:\/\/doi.org\/10.1093\/lifemedi\/lnae023 (2025).","journal-title":"Life Med."},{"key":"27751_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/nature14982","author":"Z Chao","year":"2015","unstructured":"Chao, Z. et al. RAF inhibitors that evade paradoxical MAPK pathway activation. Nature https:\/\/doi.org\/10.1038\/nature14982 (2015).","journal-title":"Nature"},{"key":"27751_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.03.018","author":"A-V Alain","year":"2021","unstructured":"Alain, A.-V. et al. SWATH-MS proteomics of PANC-1 and MIA PaCa-2 pancreatic cancer cells allows identification of drug targets alternative to MEK and PI3K inhibition. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2021.03.018 (2021).","journal-title":"Biochem Biophys Res Commun."},{"key":"27751_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","volume":"19","author":"SR Punekar","year":"2022","unstructured":"Punekar, S. R., Velcheti, V., Neel, B. G. & Wong, K. K. The current state of the art and future trends in RAS-targeted cancer therapies. Nat Rev Clin Oncol 19, 637\u2013655. https:\/\/doi.org\/10.1038\/s41571-022-00671-9 (2022).","journal-title":"Nat Rev Clin Oncol"},{"key":"27751_CR45","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.10.026","author":"Y Jingxuan","year":"2018","unstructured":"Jingxuan, Y. et al. ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells. Gastroenterology https:\/\/doi.org\/10.1053\/j.gastro.2018.10.026 (2018).","journal-title":"Gastroenterology"},{"key":"27751_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52978-z","author":"DL Vincent","year":"2024","unstructured":"Vincent, D. L. et al. Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Nat Commun https:\/\/doi.org\/10.1038\/s41467-024-52978-z (2024).","journal-title":"Nat Commun"},{"key":"27751_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-130","author":"Z Jing-Jing","year":"2014","unstructured":"Jing-Jing, Z. et al. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4\/ErbB2\/p38\/MEF2C-dependent mechanism. Mol Cancer. https:\/\/doi.org\/10.1186\/1476-4598-13-130 (2014).","journal-title":"Mol Cancer."},{"key":"27751_CR48","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00262.2016","author":"G Rachel","year":"2016","unstructured":"Rachel, G. et al. Activation of heat shock response augments fibroblast growth factor-1 expression in wounded lung epithelium. Am. J. Physiol. Lung Cell Mol. Physiol. https:\/\/doi.org\/10.1152\/ajplung.00262.2016 (2016).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"27751_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1143096","author":"Z Jing","year":"2023","unstructured":"Jing, Z. et al. Fibroblast growth factor 1 ameliorates thin endometrium in rats through activation of the autophagic pathway. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1143096 (2023).","journal-title":"Front. Pharmacol."},{"key":"27751_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2426341122","author":"C Reyan","year":"2025","unstructured":"Reyan, C. et al. Effects of the gut microbiota on placental angiogenesis and intrauterine growth in gnotobiotic mice. Proc. Natl. Acad. Sci. U S A. https:\/\/doi.org\/10.1073\/pnas.2426341122 (2025).","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"27751_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.178089","author":"T Asara","year":"2025","unstructured":"Asara, T., Nipon, C., Siriporn, C. & C.,. Exploring the potential role of fibroblast growth factors in alleviating hepatic ischemia-reperfusion injury: From in vitro insights to clinical investigations. Eur. J. Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178089 (2025).","journal-title":"Eur. J. Pharmacol."},{"key":"27751_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05244-9","author":"Z Rongrong","year":"2025","unstructured":"Rongrong, Z. et al. Human-induced pluripotent stem cell-derived exosomes promote skin wound healing through activating FGF2-mediated p38 pathway. Mol. Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-025-05244-9 (2025).","journal-title":"Mol. Cell Biochem."},{"key":"27751_CR53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174888","author":"E Molly","year":"2024","unstructured":"Molly, E. et al. FGF receptors mediate cellular senescence in the cystic fibrosis airway epithelium. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.174888 (2024).","journal-title":"JCI Insight."},{"key":"27751_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado2402","author":"L Xiuting","year":"2024","unstructured":"Xiuting, L. et al. Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.ado2402 (2024).","journal-title":"Sci. Transl. Med."},{"key":"27751_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15495","author":"B Luke","year":"2022","unstructured":"Luke, B. et al. Tumor microenvironmental 15-PGDH depletion promotes fibrotic tumor formation and angiogenesis in pancreatic cancer. Cancer Sci. https:\/\/doi.org\/10.1111\/cas.15495 (2022).","journal-title":"Cancer Sci."},{"key":"27751_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-025-09988-2","author":"S Minji","year":"2025","unstructured":"Minji, S. et al. Angiopoietin-2 binds to FGFR2, inhibits FGF-FGFR2 signaling, and delays cutaneous wound healing by inhibiting wound angiogenesis. Angiogenesis https:\/\/doi.org\/10.1007\/s10456-025-09988-2 (2025).","journal-title":"Angiogenesis"},{"key":"27751_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-1584-3","author":"J Shanshan","year":"2020","unstructured":"Shanshan, J. et al. Conditioned medium derived from FGF-2-modified GMSCs enhances migration and angiogenesis of human umbilical vein endothelial cells. Stem Cell Res. Ther. https:\/\/doi.org\/10.1186\/s13287-020-1584-3 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"27751_CR58","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333638","author":"S Xugang","year":"2025","unstructured":"Xugang, S. et al. Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling. Gut https:\/\/doi.org\/10.1136\/gutjnl-2024-333638 (2025).","journal-title":"Gut"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27751-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27751-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27751-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:08:36Z","timestamp":1766066916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27751-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27751"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27751-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Review Committee of Animal Experimentation of Yunnan University (No. YNU20241109). All experiments were performed following relevant guidelines and regulations. Manuscripts presenting studies that have be reported in accordance with the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"43804"}}